Mobic (Meloxicam)

Meloxicam, the active ingredient in Mobic, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It is indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and juvenile rheumatoid arthritis in appropriate patient groups.

GNH USA supplies Mobic as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mobic (meloxicam) is used to reduce inflammation and pain in several chronic arthritic conditions.

- Osteoarthritis: reduces joint pain and improves mobility. - Rheumatoid arthritis: decreases inflammation and slows disease progression. - Ankylosing spondylitis: alleviates spinal stiffness and pain. - Juvenile rheumatoid arthritis: controls symptoms in pediatric patients.

Mobic may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Edema: mild swelling of extremities. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Peptic ulcer or gastrointestinal bleeding. - Severe hepatic injury: elevated liver enzymes or hepatitis. - Renal impairment: acute kidney injury or worsening chronic kidney disease. - Cardiovascular events: myocardial infarction or stroke. - Anaphylaxis or severe hypersensitivity reactions.

Before prescribing Mobic, clinicians should consider several precautionary measures to minimize risk.

- Assess renal function: avoid use in severe renal impairment. - Evaluate hepatic status: monitor liver enzymes in patients with liver disease. - Cardiovascular risk: use cautiously in patients with history of heart disease or hypertension. - Gastrointestinal history: avoid in individuals with active ulcers or prior GI bleeding. - Concomitant anticoagulants: monitor for increased bleeding risk. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Mobic can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): elevated bleeding potential. - Angiotensin‑converting enzyme inhibitors or ARBs: possible reduction in renal function.

Moderate Interactions (Monitor Closely): - Diuretics: may worsen renal impairment. - Lithium: NSAIDs can raise lithium levels. - Methotrexate: reduced clearance leading to toxicity.